Ondine Biomedical Inc. (AIM:OBI)
London
· Delayed Price · Currency is GBP · Price in GBX 10.10
-0.15 (-1.46%)
Mar 9, 2026, 4:25 PM GMT
Ondine Biomedical Revenue
Ondine Biomedical had revenue of 1.01M CAD in the half year ending June 30, 2025, with 136.68% growth. This brings the company's revenue in the last twelve months to 2.20M, up 34.82% year-over-year. In the year 2024, Ondine Biomedical had annual revenue of 2.05M with 70.32% growth.
Revenue (ttm)
2.20M CAD
Revenue Growth
+34.82%
P/S Ratio
45.17
Revenue / Employee
122.39K CAD
Employees
18
Market Cap
53.25M GBP
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.05M | 846.00K | 70.32% |
| Dec 31, 2023 | 1.20M | 565.00K | 88.56% |
| Dec 31, 2022 | 638.00K | -1.93M | -75.17% |
| Dec 31, 2021 | 2.57M | 778.00K | 43.44% |
| Dec 31, 2020 | 1.79M | 258.16K | 16.84% |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
| Dec 31, 2007 | Pro | Pro | Pro |
| Dec 31, 2006 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| hVIVO | 54.47M |
| Faron Pharmaceuticals Oy | 1.14M |
| ImmuPharma | -69.96K |
| Bioventix | 13.12M |
| 4basebio | 1.78M |
| SkinBioTherapeutics | 4.64M |
| Arecor Therapeutics | 5.06M |
| Aptamer Group | 1.20M |